Final Draft (software)

Final Draft is a screenwriting software for writing and formatting a screenplay to meet the screenplay submission standards set by theater, television and film industries. The program is developed and owned by Final Draft, Inc., headquartered in Calabasas, California; the company also published Script magazine until 2011. It can also be used to write other documents such as stageplays, outlines, treatments, query letters, novels, graphic novels, manuscripts, and basic text documents.

The current version, Final Draft 9.0.4, was released in August 2014. It contains over 50 movie and television templates, and also allows users to assign computer generated voices to their characters, who then read the script aloud. Final Draft AV is a similar script-writing program which is designed for writing television videos, reality television, news, commercials, corporate and training videos, documentaries, and presentations. First released in 2001, it uses the split-page, two-column audio and video format. Final Draft AV is no longer available for sale or supported by the company. Final Draft companion applications for the iPad and iPhone are available.

FDX

FDX may refer to:

Computing:

Telecommunications:

Adrenal ferredoxin

Adrenal ferredoxin also known as adrenodoxin or adrenodoxin, mitochondrial or hepatoredoxin or ferredoxin-1 (FDX1) is a protein that in humans is encoded by the FDX1 gene. In addition to the expressed gene at this chromosomal locus (11q22), there are pseudogenes located on chromosomes 20 and 21.

Function

Ferredoxin-1 is a small iron-sulfur protein that transfers electrons from NADPH through ferredoxin reductase to a terminal cytochrome P450. This particular oxidation/reduction system is found in steroidogenic tissues, and is involved with the synthesis of bile acid and vitamin D. Ferredoxin-1 has been identified in a number of different tissues but all forms have been shown to be identical and are not tissue specific.

References

Further reading